News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
Cartography Biosciences and Pfizer Collaborate to Identify Tumour-Selective Antigens
Wednesday, January 07, 2026Cartography Biosciences Inc a biotechnology company developing antibodybased cancer treatments has entered into a strategic collaboration with Pfizer to discover tumourselective antigens
Oculis Receives U.S. FDA Breakthrough Therapy Designation for Privosegtor in Optic Neuritis
Wednesday, January 07, 2026Oculis Holding AG a global biopharmaceutical company focused on neuroophthalmology and ophthalmology has received Breakthrough Therapy Designation from the US Food and Drug Administration FDA for Privosegtor for the treatment of optic neuritis
Basilea Pharmaceutica and Prokaryotics Announce Strategic Collaboration for Novel Broad-Spectrum Antifungal Development
Wednesday, January 07, 2026Swiss biopharma leader Basilea Pharmaceutica enters exclusive global collaboration with USbased Prokaryotics to advance a firstinclass antifungal program addressing severe invasive infections
EU Pharmaceutical Rules Reform Secures Political Deal Boosting Innovation and Access
Tuesday, January 06, 2026The European Commission welcomes the political agreement between the Council and Parliament to modernise over yearold EU pharmaceutical legislation enhancing innovation supply chains and medicine availability
Switzerland to Further Solidify Leadership in European Life Sciences Ecosystem in 2026
Monday, January 05, 2026Switzerland will widen its lead as Europes premier life sciences hub in driven by structural advantages and proximity to Roche and Novartis
JPMorgan Identifies Top EU Pharma, Biotech & Life Science Stocks for 2026 with AstraZeneca Leading Rankings
Friday, January 02, 2026JPMorgan highlights AstraZeneca Novartis Bayer Argenx UCB Zealand Pharma Lonza and others as top performers in European pharma biotech and life sciences for
EU Critical Medicines Act Advances as Parliament Adopts Draft to Strengthen Supply Chains and Reduce Dependencies
Thursday, January 01, 2026The European Parliaments Public Health Committee has adopted a draft bill to boost investment in critical medicines manufacturing and enhance EU supply chain resilience
Europe's Dramatic Decline in Pharmaceutical Production Threatens Health Sovereignty
Tuesday, December 30, 2025Europe faces a critical loss of pharmaceutical manufacturing dominance to China India and the US jeopardizing health sovereignty amid fragmented supply chains and shifting investments
European Commission and Parliament reach landmark political agreement on overhaul of EU pharmaceutical legislation
Monday, December 29, 2025EU institutions have reached a landmark political agreement to overhaul general pharmaceutical legislation reshaping incentives regulatory pathways and manufacturing obligations for companies operating in Europe
EU Unveils Sweeping Reforms for Pharma, Biotech, and Medical Device Sectors to Accelerate Innovation
Friday, December 26, 2025The European Union has announced comprehensive regulatory reforms targeting the pharma biotech and medical device industries to streamline approvals reduce bureaucracy and boost innovation across Europes life sciences sector
